Arcutis Biotherapeutics Inc (ARQT)
9.35
+0.15
(+1.63%)
USD |
NASDAQ |
May 20, 16:00
9.26
-0.09
(-0.96%)
After-Hours: 20:00
Arcutis Biotherapeutics Gross Profit Margin (Quarterly): 93.43% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 93.43% |
December 31, 2023 | 83.39% |
September 30, 2023 | 96.90% |
June 30, 2023 | 85.05% |
Date | Value |
---|---|
March 31, 2023 | 71.84% |
December 31, 2022 | 83.62% |
September 30, 2022 | 62.90% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.90%
Minimum
Sep 2022
96.90%
Maximum
Sep 2023
82.45%
Average
83.62%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
AdaptHealth Corp | -13.73% |
Prestige Consumer Healthcare Inc | 54.81% |
Pfizer Inc | 77.29% |
Adverum Biotechnologies Inc | -- |
Karuna Therapeutics Inc (DELISTED) | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -187.2% |
Return on Assets | -59.96% |
Return on Invested Capital | -68.61% |
Profit Margin (Quarterly) | -71.38% |
Operating Margin (Quarterly) | -63.79% |
Return on Net Operating Assets | -419.4% |